Who Just Raised

Cloverleaf Bio, Inc.

New Haven, CT ยท Biotechnology

Cloverleaf Bio, Inc. is a biotechnology company based in New Haven, Connecticut. In a Form D filed with the SEC on September 9, 2026, it reported raising $14,799,988 from 12 investors as part of an offering of up to $29,599,977. The first sale in the offering took place on August 24, 2026.

Amount raised
$14,799,988
Offering size
$29,599,977
Investors so far
12
First sale
August 24, 2026
Securities offered
Equity
Exemption claimed
Rule 506(b)
Industry
Biotechnology
Headquarters
New Haven, Connecticut
Incorporated
Delaware, 2023
Entity type
Corporation

Filings

FiledFormRaisedOffering sizeInvestorsSource
D (new notice) $14,799,988 $29,599,977 12 SEC filing

Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.

Other health care raises in Connecticut

Company Location Sector Raised Target Filed
Thetis Pharmaceuticals LLC Deep River, CT Health Care $560K $1M
Pantera, Inc. Hartford, CT Health Care $1.4M $3.5M
Inventure, LLC Southbury, CT Health Care $82K $82K
Oxbridge Health, Inc. Norwalk, CT Health Care $38.5M $45M
Convexity Scientific Inc. New Haven, CT Health Care $10M $13M